PennyStock101

Cleveland BioLabs, Inc. 25% upside

Long
NASDAQ:CBLI   None
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.

Your Intro To Penny Stock Trading Success...

1) Sign Up for our 100% Free Email Newsletter:
http://www.PennyStock101.org

2) Follow our Telegram Channel @ https://t.me/PennyStock101

3) Join our LIVE CHAT on Discord @ https://discord.gg/qSVhafy